The Alan E. Beer Center for Reproductive Immunology & Genetics researches and treats couples who experience recurrent miscarriages, multiple pregnancy losses or repeated in vitro fertilization failures.

Preeclampsia Foundation is a 501 (c) (3) non-profit operating organization established in the year 2000 to promote safe pregnancy and post-partum research, public education and patient support. The Preeclampsia Foundation's mission is to reduce maternal and infant illness and death due to preeclampsia by supporting innovative research, raising public awareness, and helping women access safe reproductive technology, support and care. Because this disorder is transitory in nature-women become members of a silent club, each experiencing a similar crisis without the benefit of emotional, or physical preparation or the support of women who have been there before.

April 1, 2005 - American Family Physician

Thromb Haemost. 1997 Jan;77(1):39-43.

Pregnancy increases the risk of venous thromboembolism (VTE) but the true incidence is unknown. The risk of VTE continues in the post-partum period and is probably higher than during pregnancy.

Ask Lenore is an information resource for couples who are expanding their families via adoption, surrogacy, or traditional pregnancy as well as those who are experiencing infertility and/or recurrent miscarriage.

Infertility problems are diagnosed in 1 in 10 American couples, yet fully half eventually bear a child. Find out about infertility drugs, tests, and treatments such as IVF. Plus, find daily support in our online support groups.

April 1, 2005 - American Family Physician

Obstetrics & Gynecology 2004;104:336-343 © 2004 by The American College of Obstetricians and Gynecologists

Victoria Fertility Centre

Get information on stages of pregnancy, signs and symptoms, and pregnancy tests, or read about parenting styles and skills, and find parenting tips and advice.

Last modified July 17, 2005

Prescribing anticoagulants to pregnant women can be difficult and stressful. Fortunately, low-molecular-weight heparins (LMWHs) and unfractionated heparin are quite safe and efficacious when properly selected, dosed, and monitored. Maternal and fetal concerns must be considered at all times, with a careful assessment of the risks and benefits of anticoagulant therapy in each patient. Further research should help to clarify who should receive thromboprophylaxis, how to prevent adverse pregnancy outcomes in women with various thrombophilias, and how best to treat pregnant women who have a prosthetic heart valve. Cleveland Clinic Journal of Medicine February 2009 vol. 76 no. 2 113-127

Here you can subscribe free to the ORGYN Online Magazine. This is the online continuation of ORGYN, Organon's acclaimed and long-running print magazine read by 120,000 obstetricians and gynecologists worldwide

Renal disease and preeclampsia are your two biggest concerns. An expert nephrologist outlines the steps involved in differential diagnosis and management.

But Link Between Preeclampsia and Certain Malignancies Isn't Conclusive

Our mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality. We carry out this mission through research, community services, education and advocacy to save babies' lives. March of Dimes researchers, volunteers, educators, outreach workers and advocates work together to give all babies a fighting chance against the threats to their health: prematurity, birth defects, low birthweight.

Miscarriage and Perinatal Loss, Forum Moderated by a Doctor

Expert Opin Drug Saf. 2005; 4(3):583-90 (ISSN: 1744-764X).

In normal pregnancy, levels of most procoagulant factors (factors VII, VIII, X, XII, and fibrinogen) rise, while anticoagulant proteins either remain unchanged (protein C, antithrombin) or decrease (protein S). The fibrinolytic system is also altered, with increased levels of plasminogin activator inhibitor (PAI). These hemostatic changes can result in a hypercoagulable state. It has been postulated that maternal thrombophilic defects may exaggerate this hemostatic response and lead to an adverse pregnancy outcome.